Stock screenerAll disclosures →
EDGAR →
TNGX
Conviction 80HealthcareScan · Thu, Jun 25, 2026TNGX$30.13+3.47%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 7.28M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price30.13
Change+3.47%
Gap+1.29%
Rel volume0.86×
Avg volume5.83M
Avg $ vol166.99M
SMA 2027.19
SMA 5024.96
SMA 20014.79
Price vs 50+20.69%
Price vs 200+103.74%
MA stackbullish
50/200 cross—
Supertrendup · 25.26
RSI (14)59
MACD hist-0.03
MACD crossbear · 1d
Stoch %K / %D72 / 65
ADX (14)31
+DI / −DI35 / 17
RSI divergence—
MACD divergence—
ATR %+7.67%
ADR %8.23%
52w high32.90
52w low4.92
From 52w high-8.42%
Above 52w low+512.40%
New 52w highNo
SqueezeOff
Bollinger width64.99%
%B0.67
Donchian pos71.53%
Donchian high34.39
Donchian low19.43
AVWAP (52w high)29.32
vs AVWAP high+2.75%
AVWAP (52w low)14.81
vs AVWAP low+103.43%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d0.86×
Avg vol (14d)7.28M
Avg vol (20d)5.83M
Avg $ vol (20d)166.99M
Market cap4.36B
RS 3m (vs SPY)+37.23%
RS 6m (vs SPY)+234.05%
RS line new highNo
Trend template8/8
Technical rank95.6
1 week-6.69%
1 month+50.35%
3 months+44.30%
6 months+249.54%
1 year+462.13%
YTD+237.40%
P/E-42.90
P/B11.13
P/S69.86
P/FCF-31.14
EPS-0.8700
Div yield—
ROE-25.95%
ROA-23.31%
Debt/Eq—
Current27.38
EV/EBITDA—
Gross margin—
Net margin-162.85%
Rev growth48.29%
EPS growth22.03%
Price target41.64
Target upside38.20%
Analyst ratingBuy
Institutional115.32%
Ent. value4.2B
Revenue0
Net income-45.51M
Gross profit—
Free cash flow-139.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out144.65M
Employees137
ListedWed, Aug 11, 2021
Free float128.95M
Float %89.4%
Short interest33.49M
Days to cover13.0d
Short volume43.8%
Squeeze score68 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.31 · 5 est
Last EPS vs est−$0.32 vs −$0.32
Last surprise0.0% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank95.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.59
Support19.40
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TNGX
No recent disclosed trades by Congress in TNGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TNGX · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lee Sung Director · Common Stock · 2026-06-05 | Grant | 570 | $0 | 2026-06-05 | 2026-06-08 |
Ketchum John B Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
Ketchum John B Director · Common Stock · 2026-06-05 | Grant | 4K | $0 | 2026-06-05 | 2026-06-08 |
Rothenberg Mace Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
Lee Sung Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 3.57K | $0 | 2026-06-05 | 2026-06-08 |
Calhoun Lesley Ann Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
Calhoun Lesley Ann Director · Common Stock · 2026-06-05 | Grant | 4K | $0 | 2026-06-05 | 2026-06-08 |
Rothenberg Mace Director · Common Stock · 2026-06-05 | Grant | 4K | $0 | 2026-06-05 | 2026-06-08 |
Crystal Adam President, R&D · Stock Option (Right to Buy) · 2026-06-01 | Exercise | 27K | $0 | 2026-06-01 | 2026-06-03 |
Crystal Adam President, R&D · Common Stock · 2026-06-01 | Sell | 20.86K | $481K | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in TNGX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.